PSTX News and Press, Poseida Therapeutics Inc. From 05/05/21

Poseida Therapeutics to Present at BofA Securities 2021 Virtual Health Care Conference PR Newswire SAN DIEGO , May 5, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engi...

Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting PR Newswire SAN DIEGO , April 27, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietar...

Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences PR Newswire SAN DIEGO , April 8, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering plat...

Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board PR Newswire SAN DIEGO , March 23, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing propriet...

PSTX is an early-stage CAR-T and gene therapy developer. Lead asset is targeting multiple myeloma and has early-stage data. The company is well-capitalized and may become interesting in the future. For further details see: Poseida: Early Stage CAR-T And Gene Therapy Deve...

Poseida Therapeutics (PSTX): Q4 GAAP EPS of -$0.58 beats by $0.11.As of December 31, 2020, cash, cash equivalents and marketable securities were $309.2MPress Release For further details see: Poseida Therapeutics EPS beats by $0.11

Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020 PR Newswire SAN DIEGO , March 11, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizin...

Shares of Poseida Therapeutics (NASDAQ:PSTX) were jumping 21.2% higher as of 12:08 p.m. EST on Wednesday. The big gain came with the company providing a pipeline update at its virtual R&D Day today. Poseida said that its virtual R&D Day will include a presentation of a case ...

Gainers: Sunesis Pharmaceuticals (SNSS) +38%, Owens & Minor (OMI) +32%, Salarius Pharmaceuticals (SLRX) +20%, Poseida Therapeutics (PSTX) +20%, PRA Health Sciences (PRAH) +19%.Losers: Rafael (RFL) -12%, Constellation Pharmaceuticals (CNST)...

Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day Virtual R&D Day featuring key opinion leaders and Poseida's scientific team members to be hel...